ICD-10 Code A18.17 | Tuberculous female pelvic inflammatory disease Symptoms, Diagnosis, Billing

Tuberculous female pelvic inflammatory disease is a serious condition caused by Mycobacterium tuberculosis affecting the female reproductive organs. It can lead to significant morbidity, including infertility and chronic pelvic pain. Accurate coding with ICD-10 Code A18.17 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage this infectious disease effectively.

What is ICD-10 Code A18.17 for Tuberculous female pelvic inflammatory disease?

ICD-10 Code A18.17 represents Tuberculous female pelvic inflammatory disease, a complication of genital tuberculosis. This code should be used when documenting cases where tuberculosis has spread to the female reproductive system, leading to inflammation and potential complications. It is crucial for accurate clinical documentation and billing, particularly in infectious disease management.

ICD-10 Code A18.17 – Clinical Definition and Explanation of Tuberculous female pelvic inflammatory disease

Tuberculous female pelvic inflammatory disease is primarily caused by the spread of Mycobacterium tuberculosis to the pelvic organs, often resulting from a primary pulmonary infection. The condition can progress to severe complications, necessitating prompt medical intervention.

Key Clinical Features:

• Chronic pelvic pain and discomfort
• Menstrual irregularities or amenorrhea
• Fever and systemic symptoms
• Infertility or difficulty conceiving

ICD-10 Code A18.17 for Tuberculous female pelvic inflammatory disease – SOAP Notes & Clinical Use

ICD-10 Code A18.17 is utilized in SOAP notes to document the presence of Tuberculous female pelvic inflammatory disease. It aids in capturing the patient's symptoms, assessment findings, and treatment plans, relevant in both acute and chronic care settings.

What Does ICD-10 Code A18.17 for Tuberculous female pelvic inflammatory disease Mean in SOAP Notes?

In SOAP notes, ICD-10 Code A18.17 connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of Tuberculous female pelvic inflammatory disease. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code A18.17 – Tuberculous female pelvic inflammatory disease

Tuberculous female pelvic inflammatory disease requires urgent medical attention, often necessitating hospitalization for effective management.

Antibiotic Therapy:

• First-line: Isoniazid, Rifampicin, Pyrazinamide, Ethambutol for 6-12 months
• Alternative: Levofloxacin or Moxifloxacin if first-line agents are contraindicated

Supportive Care:

• Pain management with analgesics
• Nutritional support and counseling
• Monitoring for complications such as abscess formation

Infection Control:

• Isolation precautions if pulmonary tuberculosis is suspected
• Education on transmission prevention during outbreaks
• Regular screening for close contacts

How to Document Symptoms of Tuberculous female pelvic inflammatory disease (ICD-10 A18.17) in SOAP Notes

Subjective:

• Patient reports chronic pelvic pain worsening over the past month
• History of irregular menstrual cycles noted
• Complaints of fever and night sweats
• Previous diagnosis of pulmonary tuberculosis

Objective:

• Abdominal tenderness on examination
• Fever of 101°F noted during vitals
• Pelvic ultrasound shows signs of inflammation
• Laboratory tests indicate elevated inflammatory markers

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Tuberculous female pelvic inflammatory disease (ICD-10 Code A18.17)

Assessment:

• Diagnosis: Tuberculous female pelvic inflammatory disease, moderate severity
• ICD-10 Code: A18.17
• Contributing factors: History of pulmonary tuberculosis, possible exposure to infected individuals

Plan:

• Initiate first-line antibiotic therapy as per guidelines
• Educate patient on disease process and treatment adherence
• Schedule follow-up in 4 weeks to assess treatment response
• Consider referral to a specialist for further evaluation if symptoms persist

Treatment & Plan Section for ICD-10 Code A18.17 – Tuberculous female pelvic inflammatory disease

• Administer first-line antibiotics and monitor for side effects
• Provide education on the importance of completing the full course of therapy
• Regular follow-up appointments to assess symptom resolution and treatment efficacy
• Consider additional imaging or procedures if complications arise

Using ICD-10 Code A18.17 for Tuberculous female pelvic inflammatory disease in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in SOAP notes
• Use A18.17 in appropriate clinical settings, including inpatient and outpatient care
• Align treatment plans with clinical guidelines to support justified billing
• Document any relevant comorbidities or complications to enhance coding accuracy

Related ICD-10 Codes Often Used with Tuberculous female pelvic inflammatory disease

• A15.0 – Pulmonary tuberculosis, bacteriologically and histologically confirmed
• A18.2 – Tuberculosis of the genitourinary system

ICD-10 Code A18.17 in Medical Billing and Insurance for Tuberculous female pelvic inflammatory disease

ICD-10 Code A18.17 is critical for billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings and treatment plans to support the claim
• Use A18.17 in conjunction with other codes for comprehensive billing
• Ensure that the diagnosis is clearly linked to the services provided in the medical record

Common CPT Pairings: